NCT05085249View on ClinicalTrials.gov

Improving Goal Directed Medical Therapy for Device Clinic Patients With Reduced EF at UOHI: a QI Initiative (VIGILANT)

UnknownOBSERVATIONAL
Enrollment

2,500

Participants

Timeline

Start Date

July 14, 2021

Primary Completion Date

September 30, 2023

Study Completion Date

September 30, 2023

Conditions
Heart Failure
Trial Locations (1)

K1Y 4W7

RECRUITING

University of Ottawa Heart Institute, Ottawa

Sponsors

Collaborators (2)

Novartis
AstraZeneca
All Listed Sponsors
collaborator

Novartis

INDUSTRY

collaborator

Servier

INDUSTRY

collaborator

AstraZeneca

INDUSTRY

lead

Ottawa Heart Institute Research Corporation

OTHER